🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

AtriCure clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA and UK registers with AtriCure as lead sponsor. Synced 26 Sep 2026
9Current trials
5Recruiting now
0Drugs in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

AtriCure is the lead sponsor of 9 current clinical trials in our USA and UK registers. 5 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Inappropriate Sinus Tachycardia.

ClinicalTrials.gov trials by status

  • Recruiting556%
  • Active, closed444%

Trials by phase

  • Not applicable556%
  • Observational444%
01

Clinical trials sponsored by AtriCure

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Tracking Results of Ablations to Combat AF Registry Generation 2
NCT05111015 · Atrial Fibrillation
Observational Recruiting 2024-03 USA
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
NCT05110989 · ClinicalTrials.gov ↗ · Post Operative Pain
Observational Recruiting 2018-06 UK, USA
BoxX-NoAF Clinical Trial
NCT06989775 · ClinicalTrials.gov ↗ · Post Operative Atrial Fibrillation, Atrial Fibrillation, Postoperative
Not applicable Recruiting 2025-10 USA
Inappropriate Sinus Tachycardia Registry
NCT05107635 · ClinicalTrials.gov ↗ · Inappropriate Sinus Tachycardia, Postural Tachycardia Syndrome
Observational Recruiting 2022-03 USA
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
NCT06908538 · ClinicalTrials.gov ↗ · Amputation, Amputation of Lower Limb, Amputation of Upper Limb
Observational Recruiting 2025-04 USA
CONVERGE Post-Approval Study (PAS)
NCT05393180 · ClinicalTrials.gov ↗ · Chronic Atrial Fibrillation
Not applicable Active, closed 2022-04 UK, USA
HEAL-IST IDE Trial
NCT05280093 · ClinicalTrials.gov ↗ · Inappropriate Sinus Tachycardia
Not applicable Active, closed 2022-05 UK, USA
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304 · ClinicalTrials.gov ↗ · Ischemic Stroke, Systemic Embolism
Not applicable Active, closed 2023-01 UK, USA
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
NCT03732794 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
Not applicable Active, closed 2019-01 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in AtriCure trials

16 conditions
Inappropriate Sinus Tachycardia2Chronic Atrial Fibrillation1Post Operative Pain1Ischemic Stroke1Systemic Embolism1Atrial Fibrillation1Post Operative Atrial Fibrillation1Atrial Fibrillation, Postoperative1Atrial Fibrillation (AF)1Persistent Atrial Fibrillation1Longstanding Persistent Atrial Fibrillation1Postural Tachycardia Syndrome1Amputation1Amputation of Lower Limb1Amputation of Upper Limb1Amputation, Limb Loss1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in USA95
Clinical trials in UK41

A trial with sites in more than one country appears in each of those registers.

04

Questions about AtriCure trials

How many clinical trials does AtriCure sponsor?

AtriCure is the lead sponsor of 9 current trials on ClinicalTrials.gov in our USA and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are AtriCure trials recruiting?

Yes. 5 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.